Same symptoms, different conditions β here's exactly how to tell them apart.
A virus that attacks the immune system's CD4 T-cells, gradually weakening the body's ability to fight infections and cancers. No cure, but completely controllable with daily ART.
A viral infection that primarily attacks the liver. 90% of adults who acquire it will clear it naturally. A vaccine exists. Chronic carriers need monitoring and sometimes antiviral treatment.
| Feature | HIV | Hepatitis B |
|---|---|---|
| Target organ | Immune system (CD4 T-lymphocytes) | Liver (hepatocytes) |
| Vaccine available | No vaccine | Yes β highly effective 3-dose vaccine |
| Cure available | No cure; managed with lifelong ART | No cure for chronic HBV; antiviral therapy controls it |
| Most adults who get infectedβ¦ | Remain infected lifelong without ART | 90β95% clear the virus naturally within 6 months |
| Window period | 2β6 weeks (antigen); 3 months (antibody test) | 1β9 weeks for HBsAg to appear |
| How transmitted | Blood, sexual contact, mother-to-child (breastfeeding) | Blood, sexual contact, mother-to-child (100Γ more infectious than HIV) |
| Symptoms when newly infected | Flu-like illness 2β4 weeks after exposure ("acute retroviral syndrome") | Often none; some have jaundice, fatigue, dark urine |
| Long-term risk if untreated | AIDS β life-threatening opportunistic infections | Liver cirrhosis, liver cancer (hepatocellular carcinoma) |
| Test to diagnose | HIV rapid test / 4th generation Ag/Ab combo test | HBsAg (surface antigen) blood test |
| Treatment | Daily ART (tenofovir-based first-line in Nigeria) | If chronic: tenofovir or entecavir antivirals; if acute, monitor |
The target organ and prognosis differ fundamentally. HIV attacks the immune system β without treatment, the body loses its ability to fight off infections. Hepatitis B attacks the liver β most adults fight it off completely within 6 months, but 5β10% become chronic carriers who are at risk of liver scarring (cirrhosis) and liver cancer over decades. Crucially, you can be vaccinated against Hepatitis B but not HIV. Both can be transmitted by the same acts (sex, blood contact), so a single high-risk exposure warrants testing for both. People in Nigeria living with HIV should be screened for Hepatitis B co-infection, as both respond to tenofovir-based therapy.
Our doctors will review your symptoms and order exactly the right tests β no guesswork, no delay.
π¬ Chat with Us on WhatsApp